Virus-Based Expression Systems Facilitate Rapid Target In Vivo Functionality Validation and High-Throughput Screening

Abstract

Target validation is one of rate-limiting steps in the modern drug discovery. The authors developed a strategy of combining adenovirus-mediated gene transfer for efficient target functionality validation, both in vivo and in vitro, with baculovirus expression to produce sufficient quantities of protein for high-throughput screening (HTS). The incorporation of green fluorescent protein (GFP) in the adenovirus vectors accelerates recombinant adenovirus plaque purification, whereas the use of epitope and affinity tags facilitates the identification and purification of recombinant protein. In this generalized scheme, the flexible modular design of viral vectors facilitates the transition between target validation and HTS. In the example presented, functional target validation in vivo was achieved by overexpressing the target gene in cell-based models and in the mouse cortex following adenovirus-mediated gene delivery. In this context, target overexpression resulted in the accumulation of a disease-related biomarker both in vitro and in vivo. A baculovirus-based expressional system was then generated to produce enough target protein for HTS. Thus, the use of these viral expression systems represents a generalized method for rapid target functionality validation and HTS assay development, which could be applied to numerous target candidates being elucidated in gene discovery programs. (Journal of Biomolecular Screening 2003:65-71)

Keywords

Adenovirus target validation bioinformatics HTS

References

Harris S. , Foord SM : Transgenic gene knock-outs: functional genomics and therapeutic target selection . Pharmacogenomics 2000;Nov 1:433-443.

Smith GM , Hale J. , Pasnikowski EM , Lindsay RM , Wong V. , Rudge JS : Astrocytes infected with replication-defective adenovirus containing a secreted form of CNTF or NT3 show enhanced support of neuronal populations in vitro . Exp Neurol 1996;139:156-166.

Connelly S. : Adenoviral vectors for liver-directed gene therapy. Curr Opin Mol Ther 1999;1:565-572.

Ilyin SE , Plata-Salaman CR : Probe generation by PCR coupled with ligation. Nat Biotechnol 1999;17(6):608-609.

Zhang JJ , Chao L. , Chao J. : Adenovirus-mediated kallikrein gene delivery reduces aortic thickening and stroke-induced death rate in Dahl salt-sensitive rats. Stroke 1999;30:1925-1932.

Zhang JH , Chung TD , Oldenburg KR : A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4(2):67-73.

Southan C. : A genomic perspective on human proteases as drug targets. Drug Discovery Today 2001;6:681-688.

Ilyin SE , Flynn MC , Plata-Salaman CR : Fiber-optic monitoring coupled with confocal microscopy for imaging gene expression in vitro and in vivo. J Neurosci Methods 2001 ;108:91-96.

Bilang-Bleuel A. , Revah F. , Colin P. , Locquet I. , Robert J-J. , Mallet J. , et al: Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. Proc Natl Acad Sci USA 1997;94:8818-8823.

10.

Hirooka Y. , Sakai K. , Kishi T. , Takeshita A. : Adenovirus-mediated gene transfer into the NTS in conscious rats: a new approach to examining the central control of cardiovascular regulation . Ann NY Acad Sci 2001;940:197-205.

11.

Corti O. , Sanchez-Capelo A. , Colin P. , Hanoun N. , Hamon M. , Mallet J. : Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease. Proc Natl Acad Sci USA 1999;96:12120-12125.